Drug Safety Evaluation, in its fourth edition, presents an all-inclusive guide for those who are responsible for ensuring the safety of drugs and biologics to patients, healthcare providers, and those involved in the manufacture of medicinal products, to understand how the safety of products is evaluated and shepherding valuable candidates to market. 963 p.
Series: Pharmaceutical Development
- Shayne Cox Gad. PhD, DABT; He has more than 47 years of experience as a toxicologist; Statistical consultant; Manager; and Consultant on Research and Development; He is the Principal of Gad Consulting Services, Raleigh, NC (USA).
- Dexter W. Sullivan, Jr. MS, DABT; Senior toxicologist, Gad Consulting Services, Raleigh, NC (USA).
- Publication date (digital version): 2023-01.